Nofal, A.E.; AboShabaan, H.S.; Fadda, W.A.; Ereba, R.E.; Elsharkawy, S.M.; Hathout, H.M.
L-carnitine and Ginkgo biloba Supplementation In Vivo Ameliorates HCD-Induced Steatohepatitis and Dyslipidemia by Regulating Hepatic Metabolism. Cells 2024, 13, 732.
https://doi.org/10.3390/cells13090732
AMA Style
Nofal AE, AboShabaan HS, Fadda WA, Ereba RE, Elsharkawy SM, Hathout HM.
L-carnitine and Ginkgo biloba Supplementation In Vivo Ameliorates HCD-Induced Steatohepatitis and Dyslipidemia by Regulating Hepatic Metabolism. Cells. 2024; 13(9):732.
https://doi.org/10.3390/cells13090732
Chicago/Turabian Style
Nofal, Amany E., Hind S. AboShabaan, Walaa A. Fadda, Rafik E. Ereba, Sherin M. Elsharkawy, and Heba M. Hathout.
2024. "L-carnitine and Ginkgo biloba Supplementation In Vivo Ameliorates HCD-Induced Steatohepatitis and Dyslipidemia by Regulating Hepatic Metabolism" Cells 13, no. 9: 732.
https://doi.org/10.3390/cells13090732
APA Style
Nofal, A. E., AboShabaan, H. S., Fadda, W. A., Ereba, R. E., Elsharkawy, S. M., & Hathout, H. M.
(2024). L-carnitine and Ginkgo biloba Supplementation In Vivo Ameliorates HCD-Induced Steatohepatitis and Dyslipidemia by Regulating Hepatic Metabolism. Cells, 13(9), 732.
https://doi.org/10.3390/cells13090732
